"Copyright Infringer Faces Review Bombing Backlash"

In a surprising twist in the gaming world, indie game Schedule I finds itself at the center of a copyright infringement controversy, but it's the accuser, Movie Games S.A., that's feeling the heat from the community. The developers of the The Drug Dealer Simulator series have accused Schedule I of infringing on their intellectual property, claiming similarities in plot, mechanics, and user interface. Despite the ongoing investigation, no official conclusion has been reached yet.

However, fans have taken sides, and it appears that Schedule I has garnered significant support. In response to the allegations, The Drug Dealer Simulator and Drug Dealer Simulator 2 have been bombarded with negative reviews on Steam, leading to ratings of "Overwhelmingly Negative" and "Mostly Negative" for the respective games. The backlash largely stems from accusations of Movie Games S.A. bullying the indie developer, coupled with claims of their hypocrisy, as similar games had previously gone unchallenged.

Despite the controversy, The Drug Dealer Simulator series remains well-regarded in the criminal management genre, praised by both fans and critics. On the other hand, Schedule I, a new co-op crime simulation game where players ascend from a small-time dope pusher to a kingpin, launched into Early Access on PC on March 25. The game has received an "Overwhelmingly Positive" response on Steam, currently ranking as the platform's 2nd top-selling game, surpassing titles like inZOI, Monster Hunter Wilds, and the indie hit R.E.P.O.. With a peak concurrent player count of 459,075 according to SteamDB, Schedule I is making waves.

At Game8, we found Schedule I to be a surprisingly addictive and rewarding experience, earning it the nickname of a "Breaking Bad" simulator. For a deeper dive into our thoughts on Schedule I's early access release, feel free to check out our detailed article below!

Schedule I Recent Updates

Schedule I’s Copyright Infringement Accuser Gets Review Bombed on Steam

The accusation from Movie Games S.A. came to light on April 3 via the Polish Press Agency, stating that their legal analysis suggested Schedule I might have violated the IP rights of The Drug Dealer Simulator series. This has led to a strong reaction from the gaming community, with fans expressing their support for the indie title through review bombing the accuser's games.